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Background: Patients with inflammatory bowel disease (IBD) frequently appear iron deplete but whether this is a
reflection of dietary iron intakes is not known.
Methods: Dietary data were collected from 29 patients with inactive or mildly-active IBD and 28 healthy controls
using a validated food frequency questionnaire that measured intakes of iron and its absorption modifiers.
Non-haem iron availability was estimated using a recently developed algorithm. Subjects were classified for iron
status based upon data from a concomitant and separately published study of iron absorption. Absorption was
used to define iron status because haematological parameters are flawed in assessing iron status in inflammatory
conditions such as IBD.
Results: Dietary intakes of total iron, non-haem iron and vitamin C were significantly greater in IBD patients who
were iron replete compared to those who were iron deplete (by 48%, 48% and 94% respectively; p≤0.05). The
predicted percentage of available non-haem iron did not differ between these groups (19.7 ± 2.0% vs 19.3 ± 2.0%
respectively; p=0.25). However, because of the difference in iron intake, the overall amount of absorbed iron did
(2.4 ± 0.8 mg/d vs 1.7 ± 0.5 mg/d; p=0.013). No such differences were observed in the healthy control subjects.
Conclusions: In IBD, iron status is more closely related to the quality and quantity of dietary iron intake than in the
general healthy population.
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Iron deficiency is common in patients with inflammatory
bowel disease (IBD) (36- 90% prevalence [1]), a diagnosis
that encompasses Crohn’s disease and ulcerative colitis,
and contributes to a reduced quality of life [2]. In IBD,
protein and blood loss in the gastrointestinal tract con-
tribute to abnormal iron loss, especially during inflam-
matory episodes, but dietary intakes of iron are also low,
at least in subjects with Crohn’s disease [3]. This latter
finding probably results from post-disease dietary
changes, notably a reduction in the intake of fibrous
foods, such as certain breakfast cereals that may be* Correspondence: jonathan.powell@mrc-hnr.cam.ac.uk
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reproduction in any medium, provided the orfortified with iron [3]. It is plausible that reduced intakes
of both fibrous foods [3] and fortificant iron [Powell
et al. 2012 submitted] provide some relief in gastrointes-
tinal symptoms in IBD patients. Nonetheless, whether
low dietary iron intakes are associated with iron defi-
ciency in subjects with IBD has not been assessed. This,
however, is potentially important. Patients with IBD may
be especially sensitive to the gastrointestinal, adverse
effects of oral iron supplements such that intravenous
iron supplementation has been advised in clinical guide-
lines as a ‘preferred route’ in this population [2]. Thus
intravenous iron replacement and/or adverse effects
could be spared if appropriate dietary guidelines can be
developed for IBD patients that (a) help to reduce the
risk of iron deficiency developing and (b) do not them-
selves contribute to adverse effects through enhancedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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However, addressing the question of whether dietary
habits are associated with iron deficiency anaemia in this
population has been complicated by two issues: first, in
the absence of frank anaemia, routine measures of iron
status are flawed in IBD- presumably because even low
grade inflammation can influence haematological indices
[4,5]. Secondly, iron intakes are a poor marker of iron
exposure (i.e. absorption), chiefly because certain other
dietary factors can markedly inhibit or promote iron ab-
sorption by altering its availability (i.e. the fraction of
ingested iron that is at least potentially available for ab-
sorption from the intestinal lumen). In this study we
have addressed both of these issues. First, as part of a
broader programme investigating iron intakes, absorp-
tion, and quality of life in patients with IBD, iron deplete
and iron replete subjects could be genuinely separated,
based upon absorption of iron from a single oral dose
rather than conventional haematological parameters [4].
Secondly, using an iron-specific, validated food fre-
quency questionnaire and a recently developed algo-
rithm, we were able to calculate ‘available iron’ hence
taking account of absorption modifiers of dietary iron as
well as total dietary iron [6,7]. We also studied a control
group of healthy individuals, thus determining whether
our findings would be IBD-specific or reflected in the
general population as well as providing a comparison
group for the data.
Subjects and methods
Study design and participants
IBD patients (n=29; 5 with ulcerative colitis and 24 with
Crohn’s disease) were recruited from gastrointestinal
outpatient clinics at Guy’s and St Thomas’ NHS Hospital
Trust (GSTT), London, UK. Control subjects (n=28)
were recruited from a local newspaper advertisement.
Guy’s and St Thomas’ Local Research Ethics Committee
approved the study. The data presented in this paper
were collected as part of a larger programme and further
details including the absorption data have been previ-
ously published [4].
Patients
Patients, aged 18 to 65, were recruited from out-
patient gastroenterology clinics at GSTT and in all
cases IBD was diagnosed by histological and/or radio-
logical techniques. Patients with other chronic dis-
eases, pregnant and lactating females and those who
had received iron therapy within the previous 28 days
were excluded. Additionally, only patients with in-
active or mildly active disease (e.g. Harvey Bradshaw
Index < 8) were recruited for the study. Patients ful-
filling these criteria were invited to participate in thestudy. All recruited subjects had a blood sample taken
to assess traditional markers of iron status (full blood
count, ferritin, serum iron, and total serum iron bind-
ing capacity) and inflammatory status (erythrocyte
sedimentation rate, C-reactive protein), and these data
are presented elsewhere [4].
Controls
Potential subjects were recruited from an advertisement
placed in a freely available newspaper distributed pre-
dominantly within Greater London. Subjects were
initially screened by telephone to exclude anyone with
known chronic disease, gastrointestinal disease, heredi-
tary disorders of iron metabolism and those taking
proton-pump inhibitor medication or iron therapy/sup-
plements within the previous 28 days, as all these can
act as confounders. Pregnant and lactating women were
also excluded.
Dietary intake: data collection and data output
A specific iron food frequency questionnaire (FFQ) was
used to assess intakes of dietary iron and iron absorption
modifiers over the previous month. The FFQ was a
validated computerised quantitative food frequency
questionnaire that had been developed specifically
for iron and validated against weighed diet records
collected over 11 days [6]. Usually the FFQ is self-
completed by the volunteer on a computer. However,
due to restricted access for non-hospital staff to
computing facilities, it was necessary to modify the
administration of the questionnaire. Rather than the
subject directly entering their dietary intake into a
computer program the data were collected and
recorded manually by one of the authors using the
same prompts and questions as the computer
program.
Completion of this iron specific food questionnaire
entailed 4 steps : (i) overall meal frequency recall (ii)
individual meal frequency reporting (iii) ‘missing
foods’ checklist and (iv) confirmation of the informa-
tion provided. Specifically, we :(i) recorded how many times per week subjects ate
any meal or snack (e.g. breakfast 7 times per week).
(ii) used a list of 630 foods, divided into sixteen groups,
to ascertain the meals and snacks that subjects had
consumed in the previous month. In addition,
subjects reported the portion sizes and the
frequency of each meal or snack per week. To aid
estimation of portion sizes, food models and a
photographic food portion atlas [8] were used.
Subjects were asked to list the ingredients and
quantities used in composite dishes.
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pertinent to iron intake or iron absorption that was
completed to capture any foods missing from the
diet recall so far.
(iv) presented the subjects with their diet report and
asked them to confirm its accuracy or correct it.
Following the collection of dietary data from the sub-
ject, the information was entered into the computerised
iron FFQ program. The foods within the database (i.e.
the 630 in the FFQ) were only those commonly found in
the Western diet that contain iron (or zinc a), or a diet-
ary component that modifies iron absorption such as
vitamin C, animal tissue (i.e. red meat, fish or poultry),
phytate, calcium, alcohol, tea and coffee. Thus not all
foods eaten by subjects were captured by the FFQ or,
therefore, entered into the FFQ program.
Average daily intakes were calculated using a Micro-
soft Excel based computer program (MBIAT version 4.2,
Institute of Food Research, Norwich, UK) for the follow-
ing dietary components: total iron, non-haem iron, haem
iron, meat iron, vitamin C, phytate, calcium, meat/fish/
poultry, black tea equivalents and alcohol. Values for
total iron, vitamin C and calcium were calculated from
the UK Food Composition Tables and Supplements [9-16].
Meat/fish/poultry values represent the amount of animal
tissue in 100 g edible portion of food. The amount of haem
iron was calculated from the product of the meat iron
content and the proportion of haem iron in the spe-
cific meat from literature values [17,18]. Accordingly,
non-haem iron values were calculated as the difference
between haem iron and total iron. Phytate values were cal-
culated from published data [13,15,18-21]. Finally, black
tea equivalents were estimated from beverages containing
a significant tannin (iron-binding polyphenol) content
based on their inhibitory effect on iron absorption from
published data [22-24]. 100 g of black tea was assigned an
arbitrary value of 100 and other beverages containing
tannins were assigned a proportion of this value
dependent upon their inhibitory effect on iron absorption
in comparison to black tea.Dietary intakes: estimation of available (non-haem) iron
Estimated availability of dietary non-haem iron was
calculated using the recently developed algorithm of
Rickard et al. [7] namely:% Available NontHaem Iron ¼
22:42 1þ ln 1þ 0:0056
AAð Þð Þ
1þ ln 1þ 0:0008Cð Þð Þ 1þ ln 1þ 0:0033Pð Þð Þ  ðwhere: AA, ascorbic acid (mg); AT, red meat, fish and
poultry (g); C, calcium (mg); P, phytate (mg); PO, poly-
phenols from tea (mg); NH, dietary non-haem iron (mg).
The availability of dietary non-haem iron was calcu-
lated for six meal events per subject (breakfast, morning
snack, lunch, afternoon snack, evening meal and evening
snack) based on their average monthly dietary intake at
each of these meals and then an average was taken from
these to give mean daily non-haem iron availability. We
did not consider the ‘available total dietary iron’ (i.e.
available non-haem + available haem iron) because
‘available haem iron’ is typically ascribed a standard per-
centage (e.g. 25%) of total haem iron intake irrespective
of other dietary variables [7]. Thus, in comparison be-
tween groups, total haem iron entirely reflects ‘available
haem iron’, unlike the situation described herein for
non-haem iron.Classification of iron deplete and iron replete
Subjects were classified as iron deplete or replete based
upon the serum iron curves obtained following ingestion
of a single 200 mg ferrous sulphate capsule (65 mg Fe)
[4]. Based upon findings in healthy volunteers [4], iron
absorbers were defined as having a rise in serum iron
greater than 5 μmol/L from baseline in a four-hour
period post-iron ingestion whilst iron non-absorbers
had a serum iron rise of less than 5 μmol/L. This
classification was used to identify iron replete and
iron deplete subjects as traditional clinical haemato-
logical parameters (ferritin, transferrin saturation and
even soluble transferrin receptor) are not reliable
indicators of iron status in IBD patients due to being
acute phase reactants [4,5] and, apart from bone
marrow measurements, iron absorption is the best
measure of iron status [25,26].Statistical analysis
The primary objective was to compare dietary intakes of
iron and available non-haem iron between IBD patients
that were iron deplete and iron replete. Due to the lim-
ited numbers that can practically be assessed for iron
status we have presented statistically unadjusted data
(i.e. not adjusted for multiple comparisons). We present
the same data for control subjects as a reference group
and have also presented a comparison of dietary intakes
between IBD patients and controls allowing comparison1þ ln 1þ 0:0008ATð Þð Þ
1þ ln 1þ 0:0004POð ÞÞ 1þ ln 1þ 0:0424NHð Þð Þ
Table 1 Dietary intakes in IBD patients and controls measured using an iron-specific FFQ [6]
Patients (n =29) Controls (n =28) p-
valueMedian IQR Range Median IQR Range
Total dietary iron (mg/d) 11.5 8.7-14.3 4.7-27.0 10.7 8.3-14.5 4.5-44.3 0.80
Non-haem iron (mg/d) 11.2 8.1-13.7 4.3-25.1 10.5 7.8-13.8 4.2 -42 0.80
Haem iron (mg/d) 0.5 0.4-0.9 0-1.85 0.5 0.2-0.7 0-2.4 0.5
Meat, fish and poultry (g/d) 129 94-166 0-360.4 109 57-144 0-435 0.2
Vitamin C (mg/d) 74 51-113 7.4-192.7 83 61-161 13.4-315.2 0.14
Phytate (mg/d) 46 32-63 7.1-209.9 97 67-119 23-439.7 <0.001
Black tea equivalents (g/d) 583 432-1005 0-1909.71 412 118-732 0-1718.6 0.05
Calcium (mg/d) 905 650-1112 223.6-1914.4 645 475-971 158.7-2251.1 0.06
Alcohol – n (%) consumers 15 (52%) 20 (71%)
Alcohol – (g/d) consumers 7 2-13 0-90.7 10 4-17 0-49 0.08
(1)Predicted available non-haem iron (mg/d) 1.9 1.5-2.4 0.8-4.1 1.9 1.5-2.5 0.9-4.1 0.8
Abbreviations: IQR interquartile range; IBD inflammatory bowel disease; FFQ food frequency questionnaire; (1) Predicted from Rickard et al. [7].
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Mann–Whitney test and significance was assumed at
p ≤ 0.05. Values expressed are median, interquartile
range (IQR) and range unless stated otherwise.Results
A total of fifty-seven subjects (IBD n=29, controls
n=28) were included in the study. Controls (twelve
males) had a mean age of 35 (SD=11) years and BMI
of 23.4 (SD=3) kg/m2 and IBD patients (thirteen
males) had a mean age of 42 (SD=13) years and BMI







Total dietary iron (mg/d) 10.0 14
Non-haem iron (mg/d) 9.4 13
Haem iron (mg/d) 0.5 0.
MFP (g/d) 120 17
Vitamin C (mg/d) 66 12
Phytate (mg/d) 48 4
BTE (g/d) 731 47
Calcium (mg/d) 927 89
Alcohol - n (%) consumers 10 (48%) 5 (6
Alcohol - (g/d) consumers 7.8 5.
(1) predicted available non-haem iron (mg/d) 1.7 2.
Abbreviations: MFP meat,fish and poultry; BTE black tea equivalents; IBD inflammato
* ‘Iron deplete’ refers to subjects who significantly absorbed iron when tested while
† Compares dietary intakes in iron deplete and iron replete for IBD patients or contDietary intakes
Table 1 shows the dietary intakes for IBD patients and
healthy controls. The phytate intake was significantly
lower in the patient group (p<0.001), whereas the tea
consumption was significantly higher (p=0.05) for this
group when compared to the healthy control group. No
other significant differences were observed in the nutrients
investigated with our FFQ.
However, when we classified the IBD patients as iron
deplete or iron replete we observed significant differences
in mean daily intakes for total dietary iron (p=0.05),
non-haem iron (p=0.045), and vitamin C (p=0.017),









ian Median Median p- value † p- value †
.8 11.2 10.3 0.05 0.7
.9 10.8 9.8 0.045 0.8
8 0.4 0.7 0.13 0.03
7 82 143 0.07 0.005
8 83 104 0.017 0.7
4 93 111 0.7 0.3
2 392 440 0.3 0.9
9 645 615 0.6 0.8
3%) 11 (61%) 9 (90%)
6 10.3 8.9 0.7 0.13
4 1.9 1.8 0.013 0.5
ry bowel disease; (1) Predicted from Rickard et al. [7].
‘iron replete’ refers to those who did not (see Methods section).
rols.
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trol iron replete subjects had a higher overall intake
of meat and fish products (p=0.005) that was reflected
in a higher intake of haem iron (p=0.03), compared
to the iron deplete healthy subjects (Table 2).Estimation of available non-haem
The predicted percentage of available non-haem iron,
calculated using the Rickard et al. algorithm [7] did not
differ between iron deplete and iron replete subjects
both in the patient and control groups (Figure 1A). On
the contrary, the absolute quantity of non-haem iron
available for absorption was significantly lower (p=0.013)
in iron deplete IBD patients compared to iron replete
IBD patients (Figure 1B), chiefly due to the difference in
non-haem iron intake between the 2 groups. No signifi-
cant difference in the absolute quantity of non-haem
iron available for absorption was observed in the healthy
control subjects (p=0.5) (Figure 1B).Figure 1 Absorbable dietary non-haem iron. Absorbable non-haem iron
shown as mean ± SEM (A) expressed as a percentage and (B) as absolute v
inflammatory bowel disease.Discussion
We sought to determine here whether quality and/or
quantity of dietary iron ingested was associated with iron
status in patients with IBD, even if in the general popu-
lation such associations are difficult to detect [27,28].
The idea that dietary iron intakes may be more of a de-
terminant of iron status in IBD subjects than the normal
healthy population was based on several factors. In
particular, IBD patients are frequently iron deplete pla-
cing heavy emphasis upon adequate iron intakes and
availability. In addition, disease symptoms may lead to
dietary recommendations/ modifications thus altering
intakes of iron or nutrients that can modify iron absorp-
tion [3,4]. The findings presented here clearly illustrate
that iron deplete IBD patients have a history of low
non-haem iron intakes but no difference in percentage
availability compared to iron replete subjects. This is in
contrast to healthy subjects who, in this study and, as
noted above, elsewhere [27,28], seem to be less sensitive
to modest changes in non-haem iron intakes/availabilitywas calculated using the algorithm of Rickard et al. [7]. Results are
alues calculated from non-haem iron intakes (shown in Table 2). IBD,
Figure 2 Dietary intakes as a percentage of national averages.
Mean dietary data of control subjects shown as a percentage of the
mean values for intakes of males and females from the U.K. National
Diet and Nutrition Survey (NDNS).
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that haem iron intakes did differ for iron replete versus
iron deplete control subjects, so it is possible that this,
rather than non-haem iron, contributed to differences in
iron status.
The finding that non-haem dietary iron intakes may
help determine iron status in patients with IBD could
stimulate further thinking on how IBD patients are best
advised to maximise dietary iron intakes. However, care
must be exercised in this process. Firstly, as noted above,
data from this same cohort also imply that high fortifi-
cant iron intakes actually impact quality of life in a
negative fashion [Powell et al. 2012 submitted], perhaps
due to direct, adverse gastrointestinal effects of certain
forms of iron that are not naturally derived from the diet
[29-31] [Powell et al. 2012 submitted]. Secondly,
although the iron FFQ used in this study is a validated
method for collecting dietary data with respect to iron
and its absorption modifiers [6], like all forms of dietary
assessment it is not immune to measurement error. The
iron FFQ does not provide data on energy intake that
could then be used to identify likely under reporters.
However, comparison of the dietary data collected from
control subjects in this study with data from The UK
National Diet and Nutrition Survey, 2003, shows good
agreement for intakes of total dietary iron, non-haem
iron and haem iron, and reasonable agreement for vita-
min C and calcium (Figure 2). Thirdly, numbers in this
study were relatively small, being constrained by the ne-
cessity for individual iron absorption tests. Fourthly, we
did not observe lower iron intakes in patients with IBD
compared to controls, despite a much larger study
reporting this to be the case [3]. In fairness, our aimswere not to replicate these previous findings, and the
study was not powered, or indeed matched (e.g. by age),
to do so, but, rather, we wished to assess how iron
intakes were associated with iron status in IBD. None-
theless, it is worth noting that this study does echo some
similar findings to those of the larger study [3], in that
IBD patients had lower intakes of vitamin C and phytate
in comparison to healthy controls.
Thus, in conclusion, overall our data indicate that iron
status is more closely related to dietary intake in patients
with IBD than the general healthy population. However,
care must be taken in advice given to patients on modi-
fying their diet to enhance dietary iron intakes as our
studies on quality of life, concurrent with this work,
suggest that elevated fortificant iron intakes may be
associated with a reduced quality of life in patients with
IBD. The risk:benefit ratio of low versus high dietary
iron deserves further investigation in this patient group.
Endnote
aNote: Zinc intake is also captured by this FFQ but
was not a focus of our studies.
Abbreviations
IBD: Inflammatory bowel disease; GSTT: Guy’s and St Thomas’ NHS
Foundation Trust; IQR: Interquartile range; FFQ: Food frequency
questionnaire.
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